AndroForte (Testosterone)

Quick links to important sections

AndroForte (Testosterone)

Treatment option: Hypogonadism

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of AndroForte (Testosterone)

Property Description
Active ingredient Testosterone (Bio-identical)
Form Transdermal Cream (Oil-in-water emulsion)
Pharmacological class Androgenic Hormone
Common use Testosterone Replacement Therapy (TRT) for male hypogonadism
Origin Chemically identical to the natural male sex hormone

AndroForte is a prescription-only medicine that provides Testosterone for men diagnosed with clinical and biochemical evidence of testosterone deficiency (male hypogonadism). This drug is classified as an androgenic hormone, and its primary function is to serve as Androgen Replacement Therapy (ART), used to restore the body’s essential balance of the male sex hormone.


What Type of Medicine is AndroForte (Testosterone)?

AndroForte is specifically an Androgen Replacement Therapy (ART) that provides Testosterone, which is the sole active ingredient. The compound is bio-identical, meaning its molecular structure is identical to the natural hormone produced endogenously in the body. Testosterone products are intended for use as replacement therapy in men for conditions associated with a deficiency or absence of endogenous testosterone. This therapeutic approach is used when low testosterone is clinically confirmed to be contributing to the symptoms of male hypogonadism.


Composition and Drug Form: Bio-identical Hormone in a Topical Cream

The medication is supplied as a transdermal cream, which is a white, opaque, oil-in-water emulsion. This dosage form distinguishes it from hydroalcoholic gels and other topical Testosterone preparations. The cream base, which includes almond oil, provides the vehicle for topical administration. Transdermal testosterone formulations are designed to restore serum levels to the normal adult male range, which helps ensure that patients achieve the intended physiological androgen status.


General Purpose: Hormone Restoration for Physiological Balance

The overall therapeutic purpose of AndroForte is the restoration of physiological androgen status in adult men with confirmed deficiency. By supplementing the deficient male sex hormone via the skin, the treatment helps to manage the hormonal imbalance. This replacement strategy supports the normalization of functions and characteristics dependent on adequate levels of Testosterone, aiming to return the body's endocrine balance to a healthy range.

Regulatory References

  1. TGA

What side effects are possible with AndroForte (Testosterone)?

Possible Side Effects and Safety Information

Contraindications and Serious Risks

AndroForte is strictly contraindicated in men with known or suspected prostate cancer or male breast cancer. The medication must not be used by women (especially if pregnant or breastfeeding) or children, due to the high risk of fetal harm and secondary exposure leading to virilization (e.g., development of pubic hair, enlarged genitals, or aggressive behavior) in children. Serious adverse reactions reported include symptoms of blood clots (deep vein thrombosis, pulmonary embolism), severe allergic reactions, and an increased risk of cardiovascular events (e.g., heart attack, stroke).

Common Adverse Reactions

The most commonly reported side effects typically affect the application site, presenting as skin irritation, redness, dry skin, or acne. Other frequent adverse events include headache or migraine, changes in sexual drive, and prostatic disorders, such as an increase in Prostate-Specific Antigen (PSA) or benign prostatic hyperplasia (prostate enlargement).

Safety Monitoring and Precautions

Patients with certain pre-existing conditions, including severe heart, liver, or kidney disease, sleep apnoea, or a history of blood clots, require caution as testosterone may worsen these states. Due to the risk of fluid retention, swelling (oedema) with or without heart failure may occur. Regular safety monitoring is mandatory for long-term use and includes periodic blood tests to check haematocrit/haemoglobin levels (to monitor for polycythaemia), testosterone concentrations, liver function tests, and lipid profile. The prostate must also be regularly monitored via PSA and physical examination.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with topical testosterone is officially described as an exaggeration of the known adverse effects of the hormone. Acute presentations may involve symptoms affecting the cardiovascular system and Central Nervous System (CNS). Regulators note that overdose can potentially lead to life-threatening outcomes, requiring immediate medical evaluation. Exposure-related risks include the potential for secondary exposure resulting in virilization in non-users, which is classified as an overdose consideration for topical products.

Regulatory documents mandate that individuals seek medical attention immediately upon recognizing specific severe symptoms. This urgent response is required for signs such as chest pain, trouble breathing, slurred speech, or weakness in one side of the body, which may indicate a heart attack or stroke. Furthermore, emergency services must be contacted immediately if a person experiences collapse, a seizure, or inability to be awakened.

The official profile notes that no specific antidote is known for testosterone overdose. Consequently, management relies exclusively on symptomatic and supportive treatment, with required monitoring for cardiovascular and CNS stability. Following stabilization, regulatory texts describe the discontinuation of the medication as the necessary initial procedural step to manage the overdose situation effectively.

Therapeutic Uses of AndroForte (Testosterone)

What AndroForte (Testosterone) treats: Main Uses and Benefits

AndroForte is a prescription-only Testosterone Replacement Therapy (TRT) used exclusively in adult men with clinically and biochemically confirmed male hypogonadism (testosterone deficiency). It is applied as a strategy for managing the hormonal deficit, addressing the symptoms that result from this chronic endocrine imbalance. Prescription testosterone products are indicated for men who have low testosterone levels caused by specific disorders of the testicles, pituitary gland, or brain.

The primary therapeutic goal is focused on supporting the patient in situations involving a systemic imbalance. The medication assists with addressing symptom clusters such as decreased sexual desire (libido), chronic fatigue, persistent depressed mood, and reduced lean muscle mass and strength.

Enhancing Function and Stability

This medication is commonly used to help with symptoms related to systemic imbalance, providing additional symptomatic support for primary quality-of-life concerns. By managing the hormonal deficit, it contributes to easing the overall symptom load of neuropsychiatric manifestations and physical decline, thereby helping improve day-to-day comfort during symptomatic periods.

“Testosterone therapy is generally considered relevant for addressing the multiple, chronic symptoms that interfere with the functional stability and well-being of hypogonadal men.”

Quick Fact: Helps address symptom clusters
Symptom Domain: Sexual and emotional well-being
Benefit Focus: Assists with libido and helps improve day-to-day comfort

The therapy is generally considered relevant in clinical settings that involve chronic symptoms and require supportive management to help patients cope more steadily with symptom fluctuations.

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use AndroForte (Testosterone)

Official regulatory information strictly defines the eligible population for AndroForte (Testosterone) based on absolute contraindications and conditional use requirements.

Who Can Use It

Population
Adult Men diagnosed with hypogonadism, confirmed by both clinical symptoms and multiple blood testosterone level measurements.

Who Must Not Use It (Contraindications)

Group/Condition
Women (especially those pregnant or breastfeeding, due to risk of fetal harm)
Children and Adolescents (males under 18 years of age)
Men with known or suspected prostate cancer
Men with known or suspected breast carcinoma
Individuals with a known allergy to testosterone or any excipients (such as almond oil)

Conditional or Restricted Use

Patients with certain serious pre-existing conditions require strict monitoring and may need to discontinue treatment immediately if complications occur. This includes individuals with severe cardiac, hepatic, or renal insufficiency or ischemic heart disease, due to the risk of oedema leading to congestive cardiac failure. Use in elderly men requires caution due to the increased risk of prostate issues.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Officially documented interaction patterns for testosterone replacement therapy are based on effects that necessitate increased patient monitoring or carry additive risks, according to government regulatory sources. These interactions are classified as requiring vigilance for changes in laboratory parameters or fluid balance.

Drug-Drug Interactions

Co-administration with Oral Anticoagulants, such as Warfarin, is documented to potentiate the hypoprothrombinemic response. This metabolic interaction may alter the anticoagulant activity and requires frequent monitoring of the International Normalized Ratio (INR) to manage the risk of bleeding.

When co-administered with Antidiabetic Agents, including Insulin, testosterone may decrease blood glucose levels. This interaction can lead to a decrease in the required dosage of the antidiabetic medication and necessitates careful monitoring of blood sugar.

Pharmacodynamic Additive Risk

A significant pharmacodynamic interaction is documented with Corticosteroids and Adrenocorticotrophic Hormone (ACTH). Co-use may result in an additive effect that increases the risk of fluid retention (edema). This risk is officially noted as more clinically significant for patients with underlying cardiac, renal, or hepatic disease. Regulatory documents do not list any medicinal products that are formally contraindicated for co-administration due to interaction risk alone, nor do they specify mandatory timing separation rules for co-administered oral medicines.

Mechanism of Action

The mechanism of action for testosterone is based on its function as a steroid hormone, serving as an agonist for the intracellular androgen receptor (AR). After passive diffusion across the cell membrane of target tissues (including muscle, bone, and reproductive organs), testosterone binds to the AR, inducing a conformational change in the receptor protein.

This activated complex then translocates into the cell nucleus, where it acts as a transcription factor. The complex directly binds to specific DNA sequences known as androgen response elements (AREs). This binding modulates gene transcription, increasing or decreasing the rate of messenger RNA synthesis for specific proteins. Additionally, within some tissues, testosterone is enzymatically converted by 5alpha-reductase into its metabolite, dihydrotestosterone (DHT), which also binds to and activates the AR. The resulting altered protein synthesis drives key system-level actions, including the modulation of protein synthesis in muscle tissue, stimulation of erythropoiesis, and the regulation of cellular growth in androgen-dependent tissues.

Dosage and Administration Information

Official Administration Guidelines for AndroForte (Testosterone)

AndroForte is administered via the topical (transdermal) route, exclusively as a cream. The product must be measured precisely using the provided applicator for application to clean, dry, intact skin. It is intended for daily, continuous use, and the regimen requires careful procedural adherence.


Dosing Schedule and Titration

The medicine is applied once daily, preferably in the morning. The initial dose and maximum dose are dependent on the application site. For example, the standard starting dose for the torso or abdomen is typically 100 mg of testosterone (2 mL of a 5% cream), with a maximum of 200 mg daily. Conversely, the standard starting dose for the scrotum is lower, at 25 mg (0.5 mL) daily. Dose adjustments are made through titration, following the monitoring of serum testosterone concentration after a minimum of 15 days of treatment. Use is not established in males under 18 years old.


Administration Procedures

Proper use requires specific post-application procedures. The treated area must be allowed to dry completely before clothing is worn. Standard procedures include advising against washing, showering, or swimming for a set period, typically six hours after applying to the upper body, to maintain efficacy. If a dose is missed, the patient should apply the next dose at the usual time the following day and must not double the dose.

Recent Clinical Evidence

Research evidence / Overview of studies for AndroForte (Testosterone)

Evidence for Androgen Replacement Therapy in Confirmed Male Hypogonadism

Studies on Hormonal Restoration and Pharmacokinetics

Research has explored how transdermal testosterone, including the cream formulation, is observed in the body and affects hormone levels. These pharmacokinetic (PK) studies were evaluated in specific populations of adult men with confirmed low testosterone. The focus of these studies was to measure changes in total and free serum testosterone levels toward the typical adult male range. Findings describe patterns observed in the studies where hormonal measurements rose into the expected range after treatment was observed during the defined time intervals. Research provides context but not individual predictions on how fast or efficiently an individual patient may achieve these hormonal levels.

Research on Symptoms and Quality of Life

Clinical research, often in the form of Randomized Controlled Trials (RCTs), was studied for its application in men diagnosed with hypogonadism. These studies examined outcomes related to systemic or functional imbalance associated with low testosterone. Clinical measures examined changes in scores related to sexual desire (libido), depressed mood, chronic fatigue, and scales assessing quality of life.

Studies report patterns of changes measured during the study period in scores for sexual desire and quality of life in the observed populations. Findings were mixed across different RCTs when examining outcomes such as bone mineral density or certain metabolic factors, indicating that evidence quality varies across studies for these specific endpoints.


Long-term Follow-up and Durability of Response

Clinical studies monitored the duration of patient response over defined time intervals. Short-term PK research often involved follow-up periods of around 30 days, while clinical RCTs commonly observed patient changes over intermediate periods, usually ranging from 3 months to 1 year. Evidence is limited regarding the long-term effects are not fully established for the specific cream formulation beyond the first year. The extent to which these patterns translate into durable, sustained changes for individual patients is still under investigation.


Consistency of Findings and Research Uncertainty

This section will synthesize the main evidence characteristics, describing any reported inconsistencies across individual trials for certain outcomes and clarifying the key areas where more research is needed or data remain limited. The evidence landscape suggests that data show patterns related to hormonal measurements approaching the normal range. However, the certainty remains low for long-term health outcomes, such as the potential influence on cardiovascular risk or bone fracture rates. Research is ongoing to provide more definitive insight into these areas.

Frequently Asked Questions (FAQ)

Common questions about AndroForte (Testosterone) (FAQ)


Q: Why is AndroForte (Testosterone) considered a controlled substance?

A: Official regulatory agencies classify testosterone as a controlled substance, such as Schedule III in the U.S. and Schedule G in Canada. This classification is applied because testosterone is an anabolic steroid. This designation means there are strict rules for how the medicine must be prescribed and dispensed.

Q: Does using AndroForte make me infertile?

A: Official product information notes that using exogenous testosterone (testosterone from an external source) may suppress the body's natural sperm production, which is called spermatogenesis. This effect can lead to oligospermia (low sperm count) after prolonged or excessive administration. Concerns about this subject are typically discussed with a healthcare provider.

Q: Can AndroForte (Testosterone) cause hair loss or affect my existing hair?

A: Regulatory documents list alopecia (hair loss) as an uncommon adverse reaction associated with testosterone topical products. Male pattern baldness has also been reported in post-marketing experiences, though the frequency is not always specified. These are described as potential effects in the official safety information.

Q: How long does the effect of one application of AndroForte typically last?

A: Although the hormone itself has a short life in the blood, the topical cream is designed to be absorbed into the skin, creating a small depot (storage area). This sustained release pattern is consistent with the product’s once-daily application schedule, suggesting the hormone is made available to the body over approximately 24 hours.

Q: What should I do if the applied area comes into contact with another person?

A: To minimize the risk of secondary exposure and potential adverse effects in others, particularly women and children, official guidance is clear. If an unmedicated person comes into contact with the application site, their exposed skin area should be washed immediately and thoroughly with soap and water to remove any potential transferred medication.

Q: Are there common signs that the level of testosterone is too high while using AndroForte?

A: Official documents describe certain signs that may indicate the level of testosterone in the body is too high. These potential signs include too frequent or persistent erections of the penis, and ankle swelling ( edema). These potential signs are typically reviewed with a healthcare provider.

Q: What is the consensus in research about the benefit of testosterone for older men?

A: Official guidelines referenced in authoritative sources advise against routinely prescribing testosterone therapy to all men over 65 years old who have low testosterone. Guidelines indicate that the decision for treatment in this population involves a comprehensive individual assessment, primarily due to the increased caution required for prostate issues in older men.

Q: Does being overweight or underweight affect the way AndroForte works?

A: Studies indicate that a person's body composition, such as obesity, can influence hormone transport. Being overweight is associated with decreased levels of Sex Hormone-Binding Globulin ( SHBG), a protein that carries testosterone in the blood. This may be a factor reviewed by the healthcare provider when determining treatment approach.

Q: What is the difference between primary and secondary hypogonadism in relation to this treatment?

A: Hypogonadism is described as a deficiency in the male sex hormone. Primary hypogonadism is caused by a problem directly within the testicles, while Secondary hypogonadism is caused by a problem in the brain (the pituitary or hypothalamus) that controls testicular function. Both forms of low testosterone are the basis for replacement therapy.

Q: Is it normal for a healthcare provider to stop treatment after a certain period of time?

A: Official medical guidelines indicate that discontinuation of therapy is often necessitated by specific circumstances. For example, official guidelines suggest caution for patients actively planning to conceive a child due to potential fertility impacts. Treatment may also need to be discontinued if a patient develops certain severe adverse effects or prostate abnormalities like a high PSA.

Q: Can using AndroForte affect athletic drug testing results?

A: Testosterone is listed as an anabolic agent by major organizations like the World Anti-Doping Agency ( WADA). Anabolic agents are categorized as a Prohibited Substance at all times in sport. Patients using this prescription medicine should be aware of its classification relative to any athletic drug testing.

Q: Why is it described as important to wash your hands thoroughly after application?

A: Regulatory safety information strictly requires thorough hand washing with soap and water immediately after the medicine is applied. This procedure is crucial to remove any residual medication from the hands, which helps prevent the possibility of transferring the drug to other people, especially women and children, where it could cause virilization (development of male characteristics).

Q: What does 'contraindicated' mean in the context of certain conditions and AndroForte?

A: In official regulatory language, a contraindication is a specific situation or condition where the medicine must not be used. For example, it is absolutely contraindicated in men with known or suspected prostate cancer. This is because using the drug under these circumstances may be harmful to the patient.

Q: Is there any difference between the brand name AndroForte and a generic testosterone compound?

A: For any generic drug to be approved by official agencies, it must contain the same active ingredient as the brand-name product. It must also meet the same standards of quality, strength, and purity, and is required to achieve identical or nearly identical blood levels when used. This ensures that the generic is medically considered interchangeable with the brand-name medicine.

Q: Are there different forms of testosterone used in other countries compared to AndroForte?

A: Official regulatory bodies globally approve and recognize a variety of testosterone formulations for replacement therapy. These include topical gels and creams (like AndroForte), as well as transdermal patches, buccal systems, and injections. This indicates that multiple forms of testosterone replacement exist and are used in different countries.

How should AndroForte (Testosterone) be stored and disposed of?

How to Store and Dispose of AndroForte (Testosterone)

AndroForte cream must be stored according to official regulatory requirements to ensure product stability and prevent accidental exposure.

  • Storage Environment: The medication must be kept in a cool, dry place where the temperature stays below 25^circC (77^circF). It is essential to not freeze the product and store it away from heat, moisture, or direct sunlight.
  • Container Integrity: The cream must remain in its original tube and not be transferred. The cap must be replaced firmly after each use. Contents must be used within 125 days after the tube is first opened.
  • Child Safety: The product must be securely stored out of the reach of children.
  • Disposal: Any unused, expired, or damaged AndroForte cream must be returned to a pharmacist for disposal, as directed by official protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of AndroForte (Testosterone) found in:

A-Z Index: